Spots Global Cancer Trial Database for Circulating Tumor Cells to Guide Chemotherapy for Metastatic Breast Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Circulating Tumor Cells to Guide Chemotherapy for Metastatic Breast Cancer

Official Title: CirCe01 Study: Evaluation of the Use of Circulating Tumour Cells to Guide Chemotherapy From the 3rd Line of Chemotherapy for Metastatic Breast Cancer

Study ID: NCT01349842

Conditions

Breast Cancer Ductal Infiltrating Metastatic

Interventions

Blood sampling

Usual clinical and radiological criteria

Study Description

Brief Summary: Evaluation of the use of Circulating tumour Cells to guide chemotherapy from the 3rd line of chemotherapy for metastatic breast cancer.

Detailed Description: Phase III multicentre, randomized, open-label study comparing early evaluation of the efficacy of chemotherapy by determination of circulating tumour cells versus conventional clinical and radiological evaluation.